Industry News
Sanofi Cancels Heparin Substitute Semuloparin
Jul 09, 2012
The experimental drug Semuloparin which acts to prevent blood clots and was considered as an alternative to standard heparins, has been withdrawn by it's European based manufacturer Sanofi. They have announced today that they will no longer be seeking marketing approval for the experimental medication... Read More
New Guideline Provides Evidence-Based Recommendations On Use Of Sentinel Lymph Node Biopsy For Melanoma Staging In The United States
Jul 09, 2012
The American Society of Clinical Oncology (ASCO) and the Society for Surgical Oncology (SSO) have issued their first evidence-based clinical practice guideline on the use of sentinel lymph node biopsy (SLNB) to stage patients with newly diagnosed melanoma... Read More
Do Fertility Drugs Alter Risk For Cancer? Researchers Say Yes
Jul 09, 2012
According to a study published in the July 6 edition of the Journal of The National Cancer Institute, the risk of breast cancer in women who failed to conceive at least a 10-week pregnancy and were using fertility drugs was statistically considerably lower than in those who did not use fertility drugs... Read More
HPV Vaccine Reduces Spread Even In Unvaccinated
Jul 09, 2012
The Cincinnati Children's Hospital Medical Center published a study in Pediatrics today showing that non immunized teens were showing a lower infection rate of the human papillomavirus. Usually, in large populations, vaccination tends to reduce the spread of a disease even in those without the vaccine... Read More
Drinking Coffee: More Good Than Harm?
Jul 09, 2012
There was a time when the only news about coffee and health was how it was bad for the heart, likely to give us ulcers and aggravate our nerves, but now it seems this popular beverage is receiving a more favorable kind of press... Read More
Researchers Use Zebrafish To Provide Insights Into Causes And Treatment Of Human Diseases
Jul 09, 2012
Zebrafish, popular as aquarium fish, now have an important place in research labs as a model organism for studying human diseases... Read More
Leukemia And Myelodysplasia Patients May Benefit From Rabbit Antibodies
Jul 09, 2012
Researchers at Virginia Commonwealth University (VCU) Massey Cancer Center's Bone Marrow Transplant Program have demonstrated that the use of antibodies derived from rabbits can improve the survival and relapse outcomes of leukemia and myelodysplasia patients receiving a stem cell transplant from an unrelated donor... Read More
Hope For New Therapies For Liver Cancer Following Development Of Mouse Model
Jul 09, 2012
Researchers have created the first mouse model demonstrating the role of a cancer promoting gene, Astrocyte elevated gene-1 (AEG-1), in hepatocellular carcinoma, or liver cancer. The mouse model represents a critical step in understanding the molecular mechanisms of liver cancer progression and could lead to novel therapies for the disease... Read More
Discovery Has Potential To Prevent Metastasis In Prostate And Other Cancers
Jul 09, 2012
Prostate cancer doesn't kill in the prostate - it's the disease's metastasis to other tissues that can be fatal... Read More
Discovery Has Potential To Prevent Metastasis In Prostate And Other Cancers
Jul 09, 2012
Prostate cancer doesn't kill in the prostate - it's the disease's metastasis to other tissues that can be fatal... Read More
Previous Page Next Page
